Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 111

Published Date: 14 Dec 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service by Type
        1.3.1 Overview: Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Type in 2023
        1.3.3 Cell Therapy
        1.3.4 Cell-derived Products
    1.4 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market by Application
        1.4.1 Overview: Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Large Pharmaceutical Company
        1.4.3 Small and Medium-sized Pharmaceutical Company
    1.5 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size & Forecast
    1.6 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast by Region
        1.6.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region, (2019-2030)
        1.6.3 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Prospect (2019-2030)
        1.6.4 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Prospect (2019-2030)
        1.6.6 South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Lonza
        2.1.1 Lonza Details
        2.1.2 Lonza Major Business
        2.1.3 Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.1.4 Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Lonza Recent Developments and Future Plans
    2.2 uBriGene Biosciences International
        2.2.1 uBriGene Biosciences International Details
        2.2.2 uBriGene Biosciences International Major Business
        2.2.3 uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.2.4 uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 uBriGene Biosciences International Recent Developments and Future Plans
    2.3 Thermo Fisher
        2.3.1 Thermo Fisher Details
        2.3.2 Thermo Fisher Major Business
        2.3.3 Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.3.4 Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Thermo Fisher Recent Developments and Future Plans
    2.4 Creative Biolabs
        2.4.1 Creative Biolabs Details
        2.4.2 Creative Biolabs Major Business
        2.4.3 Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.4.4 Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Creative Biolabs Recent Developments and Future Plans
    2.5 REPROCELL
        2.5.1 REPROCELL Details
        2.5.2 REPROCELL Major Business
        2.5.3 REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.5.4 REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 REPROCELL Recent Developments and Future Plans
    2.6 ATCC
        2.6.1 ATCC Details
        2.6.2 ATCC Major Business
        2.6.3 ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.6.4 ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 ATCC Recent Developments and Future Plans
    2.7 Beijing CytoNiche Biotech
        2.7.1 Beijing CytoNiche Biotech Details
        2.7.2 Beijing CytoNiche Biotech Major Business
        2.7.3 Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.7.4 Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Beijing CytoNiche Biotech Recent Developments and Future Plans
    2.8 OmniaBio
        2.8.1 OmniaBio Details
        2.8.2 OmniaBio Major Business
        2.8.3 OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.8.4 OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 OmniaBio Recent Developments and Future Plans
    2.9 Histocell
        2.9.1 Histocell Details
        2.9.2 Histocell Major Business
        2.9.3 Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.9.4 Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Histocell Recent Developments and Future Plans
    2.10 FUJIFILM Diosynth Biotechnologies
        2.10.1 FUJIFILM Diosynth Biotechnologies Details
        2.10.2 FUJIFILM Diosynth Biotechnologies Major Business
        2.10.3 FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.10.4 FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
    2.11 Taiwan Bio Therapeutics
        2.11.1 Taiwan Bio Therapeutics Details
        2.11.2 Taiwan Bio Therapeutics Major Business
        2.11.3 Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.11.4 Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Taiwan Bio Therapeutics Recent Developments and Future Plans
    2.12 Encell Co., Ltd.
        2.12.1 Encell Co., Ltd. Details
        2.12.2 Encell Co., Ltd. Major Business
        2.12.3 Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.12.4 Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Encell Co., Ltd. Recent Developments and Future Plans
    2.13 Mycenax
        2.13.1 Mycenax Details
        2.13.2 Mycenax Major Business
        2.13.3 Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
        2.13.4 Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Mycenax Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service by Company Revenue
        3.2.2 Top 3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players Market Share in 2023
        3.2.3 Top 6 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players Market Share in 2023
    3.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Overall Company Footprint Analysis
        3.3.1 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Region Footprint
        3.3.2 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Company Product Type Footprint
        3.3.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Application (2019-2024)
    5.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2030)
    6.2 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2030)
    6.3 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country
        6.3.1 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2019-2030)
        6.3.2 United States Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        6.3.3 Canada Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        6.3.4 Mexico Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2030)
    7.2 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2030)
    7.3 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country
        7.3.1 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2019-2030)
        7.3.2 Germany Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        7.3.3 France Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        7.3.5 Russia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        7.3.6 Italy Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region
        8.3.1 Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Region (2019-2030)
        8.3.2 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        8.3.3 Japan Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        8.3.4 South Korea Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        8.3.5 India Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        8.3.7 Australia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2030)
    9.2 South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2030)
    9.3 South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country
        9.3.1 South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2019-2030)
        9.3.2 Brazil Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        9.3.3 Argentina Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country
        10.3.1 Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2019-2030)
        10.3.2 Turkey Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)
        10.3.4 UAE Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Drivers
    11.2 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Restraints
    11.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Industry Chain
    12.2 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Upstream Analysis
    12.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Midstream Analysis
    12.4 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Lonza Company Information, Head Office, and Major Competitors
 Table 6. Lonza Major Business
 Table 7. Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 8. Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Lonza Recent Developments and Future Plans
 Table 10. uBriGene Biosciences International Company Information, Head Office, and Major Competitors
 Table 11. uBriGene Biosciences International Major Business
 Table 12. uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 13. uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. uBriGene Biosciences International Recent Developments and Future Plans
 Table 15. Thermo Fisher Company Information, Head Office, and Major Competitors
 Table 16. Thermo Fisher Major Business
 Table 17. Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 18. Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. Creative Biolabs Company Information, Head Office, and Major Competitors
 Table 20. Creative Biolabs Major Business
 Table 21. Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 22. Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. Creative Biolabs Recent Developments and Future Plans
 Table 24. REPROCELL Company Information, Head Office, and Major Competitors
 Table 25. REPROCELL Major Business
 Table 26. REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 27. REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. REPROCELL Recent Developments and Future Plans
 Table 29. ATCC Company Information, Head Office, and Major Competitors
 Table 30. ATCC Major Business
 Table 31. ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 32. ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. ATCC Recent Developments and Future Plans
 Table 34. Beijing CytoNiche Biotech Company Information, Head Office, and Major Competitors
 Table 35. Beijing CytoNiche Biotech Major Business
 Table 36. Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 37. Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. Beijing CytoNiche Biotech Recent Developments and Future Plans
 Table 39. OmniaBio Company Information, Head Office, and Major Competitors
 Table 40. OmniaBio Major Business
 Table 41. OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 42. OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. OmniaBio Recent Developments and Future Plans
 Table 44. Histocell Company Information, Head Office, and Major Competitors
 Table 45. Histocell Major Business
 Table 46. Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 47. Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 48. Histocell Recent Developments and Future Plans
 Table 49. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
 Table 50. FUJIFILM Diosynth Biotechnologies Major Business
 Table 51. FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 52. FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 53. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
 Table 54. Taiwan Bio Therapeutics Company Information, Head Office, and Major Competitors
 Table 55. Taiwan Bio Therapeutics Major Business
 Table 56. Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 57. Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 58. Taiwan Bio Therapeutics Recent Developments and Future Plans
 Table 59. Encell Co., Ltd. Company Information, Head Office, and Major Competitors
 Table 60. Encell Co., Ltd. Major Business
 Table 61. Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 62. Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 63. Encell Co., Ltd. Recent Developments and Future Plans
 Table 64. Mycenax Company Information, Head Office, and Major Competitors
 Table 65. Mycenax Major Business
 Table 66. Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product and Solutions
 Table 67. Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 68. Mycenax Recent Developments and Future Plans
 Table 69. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (USD Million) by Players (2019-2024)
 Table 70. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Share by Players (2019-2024)
 Table 71. Breakdown of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 72. Market Position of Players in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 73. Head Office of Key Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players
 Table 74. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Company Product Type Footprint
 Table 75. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market: Company Product Application Footprint
 Table 76. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service New Market Entrants and Barriers to Market Entry
 Table 77. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Mergers, Acquisition, Agreements, and Collaborations
 Table 78. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (USD Million) by Type (2019-2024)
 Table 79. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Share by Type (2019-2024)
 Table 80. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Forecast by Type (2025-2030)
 Table 81. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2024)
 Table 82. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Forecast by Application (2025-2030)
 Table 83. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 84. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 85. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 86. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 87. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2019-2024) & (USD Million)
 Table 88. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2025-2030) & (USD Million)
 Table 89. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 90. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 91. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 92. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 93. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2019-2024) & (USD Million)
 Table 94. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2025-2030) & (USD Million)
 Table 95. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 96. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 97. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 98. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 99. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Region (2019-2024) & (USD Million)
 Table 100. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Region (2025-2030) & (USD Million)
 Table 101. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 102. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 103. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 104. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 105. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2019-2024) & (USD Million)
 Table 106. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2025-2030) & (USD Million)
 Table 107. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2019-2024) & (USD Million)
 Table 108. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type (2025-2030) & (USD Million)
 Table 109. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2019-2024) & (USD Million)
 Table 110. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application (2025-2030) & (USD Million)
 Table 111. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2019-2024) & (USD Million)
 Table 112. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Country (2025-2030) & (USD Million)
 Table 113. Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Upstream (Raw Materials)
 Table 114. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Typical Customers


List of Figures
 Figure 1. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Picture
 Figure 2. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Type in 2023
 Figure 4. Cell Therapy
 Figure 5. Cell-derived Products
 Figure 6. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Application in 2023
 Figure 8. Large Pharmaceutical Company Picture
 Figure 9. Small and Medium-sized Pharmaceutical Company Picture
 Figure 10. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 11. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 12. Global Market Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 13. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Region (2019-2030)
 Figure 14. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Region in 2023
 Figure 15. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 16. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 17. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 18. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 19. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 20. Company Three Recent Developments and Future Plans
 Figure 21. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Share by Players in 2023
 Figure 22. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 23. Market Share of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service by Player Revenue in 2023
 Figure 24. Top 3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players Market Share in 2023
 Figure 25. Top 6 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players Market Share in 2023
 Figure 26. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Share by Type (2019-2024)
 Figure 27. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share Forecast by Type (2025-2030)
 Figure 28. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Share by Application (2019-2024)
 Figure 29. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share Forecast by Application (2025-2030)
 Figure 30. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Type (2019-2030)
 Figure 31. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Application (2019-2030)
 Figure 32. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Country (2019-2030)
 Figure 33. United States Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 34. Canada Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 35. Mexico Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 36. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Type (2019-2030)
 Figure 37. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Application (2019-2030)
 Figure 38. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Country (2019-2030)
 Figure 39. Germany Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 40. France Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 41. United Kingdom Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 42. Russia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 43. Italy Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 44. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Type (2019-2030)
 Figure 45. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Application (2019-2030)
 Figure 46. Asia-Pacific Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Region (2019-2030)
 Figure 47. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 48. Japan Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 49. South Korea Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 50. India Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 51. Southeast Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 52. Australia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 53. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Type (2019-2030)
 Figure 54. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Application (2019-2030)
 Figure 55. South America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Country (2019-2030)
 Figure 56. Brazil Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 57. Argentina Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 58. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Type (2019-2030)
 Figure 59. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Application (2019-2030)
 Figure 60. Middle East & Africa Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value Market Share by Country (2019-2030)
 Figure 61. Turkey Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 62. Saudi Arabia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 63. UAE Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Consumption Value (2019-2030) & (USD Million)
 Figure 64. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Drivers
 Figure 65. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Restraints
 Figure 66. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Trends
 Figure 67. Porters Five Forces Analysis
 Figure 68. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Industrial Chain
 Figure 69. Methodology
 Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lonza
uBriGene Biosciences International
Thermo Fisher
Creative Biolabs
REPROCELL
ATCC
Beijing CytoNiche Biotech
OmniaBio
Histocell
FUJIFILM Diosynth Biotechnologies
Taiwan Bio Therapeutics
Encell Co., Ltd.
Mycenax

Related Reports

Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Supply, Demand and Key Producers, 2024-2030

Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Supply, Demand and Key Producers, 2024-2030

date 14 Dec 2024

date Medical Care

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.

Product Tags

Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>